News
The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...
UK pharma major GSK (LSE: GSK) yesterday announced that the US Food and Drug Administration (FDA) has approved Nucala ...
A four-year-old Pakistani girl diagnosed with severe thalassemia has been successfully treated with a Chinese-developed ...
BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...
Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...
The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...
The Central Bureau of Investigation (CBI) in Bengaluru has partnered with the postal department to use Speed Post for ...
Hold out your hands, palms up, and move them so they are on top of each other. With a little experimentation—and perhaps a ...
Billy Joel has cancelled several upcoming concerts due to a diagnosis of Normal Pressure Hydrocephalus, a rare but ...
ATLANTA and BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- ABLi Therapeutics ("ABLi”), a biotechnology company developing ...
They never give you a straight answer about where they’re going, who they’re with, or what they’re doing. Every response is a ...
Regeneron Trial Team Talks $406.8M Win in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen
Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results